Alembic Pharmaceuticals Limited

Kvartální Please find attached Unaudited Financial Results for the Quarter ended 30th June, 2026. FY2027 · Q1BSEPDF 4. srp 2026 před 3 měs. Výroční Annual Report FY2026 FY2026BSEPDF 10. čvc 2026 před 4 měs. Výroční Please fin enclosed herewith Audited Financial Results for the quarter and Financial Year ended 31st March, 2026. FY2026BSEPDF 15. kvě 2026 před 5 měs. Kvartální Unaudited financial results for the quarter and nine months ended 31st December, 2025 FY2026 · Q3BSEPDF 5. úno 2026 před 9 měs. Kvartální Please find attached unaudited financial results for the quarter and half year ended 30th September, 2025 FY2026 · Q2BSEPDF 4. lis 2025 před 1 r. Kvartální Please find the unaudited financial Results for the quarter ended results 30th June, 2025. FY2026 · Q1BSEPDF 5. srp 2025 před 1 r. Výroční Annual Report FY2025 FY2025BSEPDF 16. čvn 2025 před 1 r. Výroční Please find attached herewith the Financial Results for the quarter and Financial Year ended 31st March, 2025 FY2025BSEPDF 6. kvě 2025 před 1 r. Kvartální Results for the quarter and nine months ended 31st December, 2024 FY2025 · Q3BSEPDF 3. úno 2025 před 2 r. Kvartální The exchange is hereby informed that the Board of Directors at their meeting held today has approved the Unaudited Financial Results for the quarter and half year ended September, 2024 FY2025 · Q2BSEPDF 7. lis 2024 před 2 r. Kvartální The exchange is hereby informed that the Board of Directors in their Meeting held today has approved the Unaudited Financial Results for the Quarter ended June, 2024. FY2025 · Q1BSEPDF 8. srp 2024 před 2 r. Výroční Annual Report FY2024 FY2024BSEPDF 21. čvn 2024 před 2 r. Výroční The exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its Meeting held today inter alia approved the Audited Financial results for the Quarter .... FY2024BSEPDF 9. kvě 2024 před 2 r. Kvartální Please find attached herewith the Unaudited Financial results for the quarter and half year ended 31st December, 2023 FY2024 · Q3BSEPDF 5. úno 2024 před 3 r. Kvartální PLease find attached the Results FY2024 · Q2BSEPDF 7. lis 2023 před 3 r. Kvartální Please find enclosed the Unaudited Financial Results for the qtr ended 30th June, 2023 FY2024 · Q1BSEPDF 4. srp 2023 před 3 r. Výroční Annual Report FY2023 FY2023BSEPDF 21. čvn 2023 před 3 r. Výroční The exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia Approved the Audited Financial Results for the quarter .... FY2023BSEPDF 5. kvě 2023 před 3 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved .... FY2023 · Q3BSEPDF 1. úno 2023 před 4 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved .... FY2023 · Q2BSEPDF 11. lis 2022 před 4 r. Výroční Annual Report FY2022 FY2022BSEPDF 19. zář 2022 před 4 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved: .... FY2023 · Q1BSEPDF 4. srp 2022 před 4 r. Výroční With reference to the captioned matter, we would like to inform that pending the release of XBRL template in the new format prescribed by SEBI vide its Circular dated 22nd November, 2021 .... FY2022BSEPDF 16. kvě 2022 před 4 r. Kvartální Unaudited Financial Results for the quarter and nine months period ended 31st December, 2021. Please find enclosed herewith standalone and consolidated financial results of the .... FY2022 · Q3BSEPDF 10. úno 2022 před 5 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2022 · Q2BSEPDF 10. lis 2021 před 5 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2022 · Q1BSEPDF 26. čvc 2021 před 5 r. Výroční Annual Report FY2021 FY2021BSEPDF 15. čvn 2021 před 5 r. Výroční Please refer attached file with the attachments FY2021BSEPDF 4. kvě 2021 před 5 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2021 · Q3BSEPDF 19. led 2021 před 6 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2021 · Q2BSEPDF 22. říj 2020 před 6 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2021 · Q1BSEPDF 22. čvc 2020 před 6 r. Výroční Annual Report FY2020 FY2020BSEPDF 11. čvn 2020 před 6 r. Výroční Please refer attachment for details. FY2020BSEPDF 22. kvě 2020 před 6 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2020 · Q3BSEPDF 22. led 2020 před 7 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2020 · Q2BSEPDF 25. říj 2019 před 7 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2020 · Q1BSEPDF 29. čvc 2019 před 7 r. Výroční Annual Report FY2019 FY2019BSEPDF 10. čvn 2019 před 7 r. Výroční Alembic Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 2019 2. Consolidated Financial Results for the period .... FY2019BSEPDF 8. kvě 2019 před 7 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2019 · Q3BSEPDF 22. led 2019 před 8 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2019 · Q2BSEPDF 22. říj 2018 před 8 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2019 · Q1BSEPDF 27. čvc 2018 před 8 r. Výroční Approved the Audited Financial Results of the Company for the financial year ended 31st March, 2018. FY2018BSEPDF 16. kvě 2018 před 8 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2018 · Q3BSEPDF 31. led 2018 před 9 r. Kvartální With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited .... FY2018 · Q2BSEPDF 7. lis 2017 před 9 r. Výroční The audited standalone and consolidated financial results for the quarter and year ended 31st March, 2017 of the Company under Ind AS (Statement), which were approved and taken on record .... FY2017BSEPDF 10. kvě 2017 před 9 r. Kvartální Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2016 The Unaudited Standalone results for the Quarter ended December 31, 2016: .... FY2017 · Q3BSEPDF 25. led 2017 před 10 r. Kvartální Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2016 The Unaudited Standalone results for the Quarter ended September 30, 2016 .... FY2017 · Q2BSEPDF 25. říj 2016 před 10 r. Kvartální Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended June 30, 2016: The Unaudited Standalone results for the Quarter ended June 30, 2016 The .... FY2017 · Q1BSEPDF 29. čvc 2016 před 10 r. Výroční Alembic Pharmaceuticals Ltd has announced the following results for the quarter & year ended March 31, 2016: The Audited Standalone results for the Quarter ended March 31, 2016 .... FY2016BSEPDF 27. dub 2016 před 11 r. Kvartální Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2015: The Unaudited Standalone results for the Quarter ended December 31, 2015 .... FY2016 · Q3BSEPDF 21. led 2016 před 11 r. Kvartální Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2015 The Unaudited Standalone results for the Quarter ended September 30, 2015: .... FY2016 · Q2BSEPDF 27. říj 2015 před 11 r. Kvartální Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended June 30, 2015 The Un-Audited Standalone results for the Quarter ended June 30, 2015: The .... FY2016 · Q1BSEPDF 31. čvc 2015 před 11 r. Výroční Alembic Pharmaceuticals Ltd has submitted to BSE a Copy of the Auditors Report for the period ended March 31, 2015. FY2015BSEPDF 29. kvě 2015 před 11 r. Kvartální Alembic Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2014: The Unaudited Standalone results for the Quarter ended December 31, 2014 .... FY2015 · Q3BSEPDF 4. úno 2015 před 12 r.